Obstructive sleep apnea (OSA) is the most common form of sleep-disordered breathing (SDB). It is a partial or complete collapse of the upper airway caused by the relaxation of the muscles controlling the soft palate and tongue. The prevalence of OSA has been increasing steadily, and as per estimates, it affects ~3% to 20% of the general population.
Rapid Shift Towards Home Sleep Apnea Test (HSAT) Fuels the Market Demand
The traditional way of sleep apnea testing required an overnight stay at a sleep lab. However, the trend is fast-changing now and home sleep tests are now growing in popularity. A home sleep apnea test (HSAT) is an overnight test that is conducted outside the hospital or sleep lab. These tests are conducted using a special device that measures sleep patterns during the night. HSATs cost less, generally require only a few monitors & straps, and can take place in the comfort of a personâ€™s home.
A home sleep apnea test (HSAT) is financially more friendly. It costs ~ $200 to $600, which is relatively less than $800 to $3,000 for an overnight visit to a sleep lab. Also, insurers are increasingly requiring HSAT as a first step before paying for an in-lab sleep apnea test.â€ – Product Manager, Leading Sleep Apnea Diagnostic Device Manufacturer, United States
Favorable Reimbursement of Sleep Apnea Devices in Leading Market Regions
The diagnosis and treatment of obstructive sleep apnea in the US are covered when Medicare coverage criteria are met. Medicare Part B (Medical Insurance) covers Type I, II, III, and IV sleep tests and devices if you have clinical signs and symptoms of sleep apnea.
â€¢ In the US, the diagnosis of OSA is covered. Examples of covered diagnostic services include – Oximetry Testing, Polysomnography and Sleep Studies, and Home Sleep Studies.
â€¢ The treatment of OSA is also covered in the US. Examples of covered treatments include – Continuous Positive Airway Pressure (CPAP), Respiratory Assist Devices including Bilevel Positive Airway Pressure (BiPAP), Mandibular Devices/Oral Appliances.
Organic and Inorganic Growth Strategies Adopted by Market Players to Establish Their Foothold in Sleep Apnea Devices Market
The global sleep apnea devices market is marked by the presence of both established and new players. Players operating in the market adopt both organic and inorganic growth strategies such as new product launches, and partnerships to garner market share. For instance,
â€¢ In December 2021, ZOLLÂ® Medical Corporation, completed the acquisition of Itamarâ„¢ Medical Ltd., a medical device and digital health company that provides at-home testing for sleep apnea.
â€¢ In February 2021, GoPAPfree, a homecare provider of oral appliance therapy for obstructive sleep apnea launched a new oral appliance – O2Vent Optima.
The global sleep apnea devices market is a lucrative market which is set to witness a decent growth in the upcoming years due to technological advancements in diagnostic and therapeutic sleep apnea devices, increasing awareness campaigns & initiatives run by governments and manufacturers across the world, and rising prominence & usage of oral appliances.
The sleep apnea devices market is marked by the presence of major industry players such as ResMed, Philips Respironics, Fisher & Paykel Healthcare, SomnoMed, Itamar Medical, Inspire Medical Systems, Compumedics, Oventus Medical, Natus Medical, Drive DeVilbiss Healthcare, Whole You, BMC Medical, among others.
Browse Detailed Research Insights on Sleep Apnea Devices Market @ https://meditechinsights.com/sleep-apnea-devices-market/